Kaken Pharmaceutical (4521) · FactSoftened
Increase in pharmaceutical-business production
First written in FY2019-Q1. 2 of 5 entries say "Advanced", first in FY2019. Latest entry: FY2026.
5entries
9years
0from disclosures
How it moved
Same theme, other companies
Pharmaceutical-industry production output fluctuationsA theme 1 companies write about · 0 as a headwind · 0 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2026SoftenedAnnual report
「Pharmaceutical business 36,272 △9.7」
Annual pharmaceutical-business production was ¥36,272 million, down 9.7% from the previous fiscal year, weakening the previously cited theme of increasing production. - FY2022AdvancedAnnual report
「Pharmaceutical-business production was ¥38,157 million, up 3.0% from the previous fiscal year.」
Pharmaceutical-business production, which had declined 8.0% year on year in the previous fiscal year, turned upward to ¥38,157 million, up 3.0% from the previous fiscal year. - FY2021SoftenedAnnual report
「Pharmaceutical-business production was ¥37,050 million, down 8.0% from the previous fiscal year.」
Pharmaceutical-business production, which had increased 20.2% year on year in the previous fiscal year, was ¥37,050 million in the current fiscal year, down 8.0%, weakening the theme of increasing production. - FY2019AdvancedAnnual report
「Pharmaceutical-business production was ¥45,967 million, up 20.2% from the previous fiscal year.」
Annual pharmaceutical-business production was ¥45,967 million, up 20.2% from the previous fiscal year. - FY2019-Q1First statedAnnual report
「During the cumulative first quarter of the current fiscal year, pharmaceutical-business production increased significantly to ¥12,861 million, up 33.1% year on year.」
Pharmaceutical-business production was reported at ¥12,861 million, up 33.1% year on year.